Contact FICCI
Pharmaceuticals
- The pharmaceutical industry, currently valued at USD 50 Bn and is expected to reach USD 130 Bn by 2030.
- The Indian pharmaceutical sector grew at a modest CAGR of 6.6 percent from 2016 to 2019 and it is predicted to rise at a CAGR of 12.3 percent from 2020 to 2030, attaining USD130 billion goal.
- The Indian pharmaceutical industry is the world's third largest by volume and fourteenth largest in terms of value.
- The COVID-19 pandemic has shown that India can not only innovate but also rapidly distribute time-critical drugs to every part of the globe.
- Indian medicines are preferred worldwide because of the low price and high quality, thereby rightly making the country the “pharmacy of the world”.
- Globally the country is the largest provider of generic drugs with a 20 percent share by volume and is known for its affordable vaccines and generic medications.
FICCI Pharma: Key Activities
- FICCI Pharma Team work closely with the government on policy issues, enhancing efficiency, competitiveness and expanding business opportunities for industry through a range of specialized services and global linkages. It also provides a platform for sector specific consensus building and networking. It has been actively involved in organizing stakeholder consultations/Roundtable Meetings, conferences and seminars, providing an opportunity for interaction between the industry and the policy makers, to identify the various impediments to the growth and functioning of the industry and to come out with prospective solutions.
- FICCI in partnership with the Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers organizes the "India Pharma and India Medical Devices" annual flagship event in the pharma & Medical Device sector. This event provides a unique platform to the stakeholders to deliberate and address key issues, identify challenges and chart a road map for India to take a rightful place as a preferred destination of choice for Drug Discovery, Research & Development and Manufacturing to become globally competitive.
Team Leader
Manoj Mehta
Senior DirectorTimeline
Govt working on a scheme to strengthen Indian Medical Device sector: Secretary, Department of Pharmaceuticals, GoI
Dr Mansukh Mandaviya inaugurates 51 greenfield projects under PLI scheme for Bulk Drugs and Medical Devices
Bhagwanth Khuba, Union Minister of State for Chemicals & Fertilizers, GoI addresses valedictory session of ‘India MedTech Expo 2023’, Gandhinagar,Gujarat
Government has formulated a scheme namely ‘Promotion of Research and Innovation in Pharma MedTech Sector’
World eager to invest in India’s MedTech sector: Dr Mansukh Mandaviya
Govt adopting holistic approach to make India a global hub of Medical Devices, set to become $50 billion industry soon: Dr Mansukh Mandaviya
2nd Pharmaceutical Task Force Meeting for development of a Self-Regulatory, Evidence-based code of marketing for antibiotics, focusing on the primary care setting, in association with Oasis Consortium
Multi-Stakeholder Workshop on "Role of Policy in enhancing awareness around Vaccine-Preventable Diseases"
Cholesterol check must become part of diabetes and BP screening to improve India's Heart Health: Experts
National Round Table on Unmet needs in Heart Health - Elevating the under-rated risk factors
Pharmaceutical Task Force for development of a Self-Regulatory, Evidence-based code of marketing for antibiotics, focusing on the primary care setting, in association with Oasis Consortium
Consultation on Evidence-based Marketing of Antibiotics in Association with Oasis Consortium
Pharmacoeconomics can aid policy makers and healthcare providers in evaluating affordability and access to reasonable drug use: Dr Sangita Reddy, Immediate Past President, FICCI
Virtual Conclave on Integrating Methods of Pharmaco-economics to accelerate Healthcare Transformation 2.0 (IMPACT 2.0)
Indian Pharma market is expected to grow to US$ 130 billion by 2030: DV Sadananda Gowda
State governments geared up to tackle vision care during pandemic: Experts
Central and West conclave of the Spotlight on Visually Impaired in the wake of COVID-19
Need to create more awareness across the country on vision care: Industry Experts
Govt to soon formulate comprehensive eye care package for visually impaired: Economic Advisor, MoH&FW
e-Pharmacies can collaborate with CSCs to improve healthcare access in rural areas: MoS Health & Family Welfare
FICCI Statement on Bulk Drug Park and Production Linked Incentive (PLI) Scheme
FICCI applauds ICMR strategy for calibrated ramping up of the covid-19 testing
Govt to come up with regulatory guidelines for OTC drugs - Dy Drug Controller, MoH&FW
Quality, trust, transparency critical for the healthcare industry: Joint Secretary, Department of Commerce
Need for effective public health approach on the ground to control COVID-19: Dr V K Paul, Member, NITI Aayog
Industry should come forward to develop Pharma and Medical Devices parks - Mansukh Mandaviya
Virtual Healthcare & Hygiene Expo 2020
Need to create more awareness in rural, tribal areas on Sickle Cell disease and its management - Arjun Munda
National Sickle Cell Conclave: World Sickle Cell Day 2020
FICCI launches first international 'Virtual Healthcare and Hygiene Expo 2020'
FICCI welcomes Cabinet decision on Bulk Drug Parks
India Pharma 2020 and India Medical Device 2020 focuses on clarity on changing regulatory scenarios
India Pharma 2020
India Medical Device 2020
Indian Analytical Congress - 2019
India Pavilion @ Pharmtech & Ingredients Expo
INDIA PAVILION AT PHARMATECH EXPO 2019
Access to affordable medical care and National Health Protection Scheme, priority of Government: D V Sadananda Gowda
India Pharma 2019 & India Medical Device 2019 on 18-19 Feb. in Bengaluru
India Pavilion at Pharmtech & Ingredients Expo
knowledge paper on "Towards Quality Excellence: Journey of the Indian Pharmaceutical Industry"
FICCI launches Self-regulation Code of Conduct for the e-pharmacy sector
FICCI welcomes Department of Pharmaceutical's move towards broadbased stakeholder consultations
Indian Pharma sector poised to become future world hub
Realising "Make in India"- Journey to become the most preferred manufacturer of high quality affordable medicines
Indian life sciences: Vision 2030 - Expanding global relevance and driving domestic access
FICCI Life Sciences Conference 2015 'Pharma Vision 2030: Building India's Global Relevance'
Regional GMP Strengthening Workshop for Indian Pharmaceutical Manufacturers and State Regulators” Focused on GMP in production of Active Pharmaceutical Ingredients and Oral Solid Dosage Forms
Indian Pharma Summit
GMP Strengthening for Indian Pharmaceutical Manufacturers focused on GMP in production of Active Pharmaceutical Ingredients and Oral Solid Dosage Forms
Leading journos recommend women to organize as pressure groups to increase their participation and numbers in politics
India Pharma Summit 2013-14
Prolonged crisis in Ukraine could affect Indian pharma companies
Regional workshops on GMP Strengthening for Indian Pharmaceutical Manufacturers focused on GMP in production of Active Pharmaceutical Ingredients and Oral Solid Dosage Forms
Roundtable Discussion with Indian Pharmaceuticals & Diagnostics Industry Leaders & UNITAID Executive Director
Joint China-India Tendering for Global Pharma Export Orders Possible Given China's Strengths in API Production, India's Capability in Formulations & Ability to Prepare Bid Documents: China Chamber
2nd India Pharma Summit
India Pharma Summit - 20100
India Pharma Summit 2009
Global Pharma Companies Looking to India Advantage for Clinical Research Services: FICCI - E&Y Paper
Aug, 2023
Jan, 2023
2nd Pharmaceutical Task Force Meeting for development of a Self-Regulatory, Evidence-based code of marketing for antibiotics, focusing on the primary care setting, in association with Oasis Consortium
Jan 12, 2023
Dec, 2022
Multi-Stakeholder Workshop on "Role of Policy in enhancing awareness around Vaccine-Preventable Diseases"
Dec 19, 2022
Nov, 2022
National Round Table on Unmet needs in Heart Health - Elevating the under-rated risk factors
Nov 30, 2022
Pharmaceutical Task Force for development of a Self-Regulatory, Evidence-based code of marketing for antibiotics, focusing on the primary care setting, in association with Oasis Consortium
Nov 24, 2022Sep, 2022
Aug, 2022
Consultation on Evidence-based Marketing of Antibiotics in Association with Oasis Consortium
Aug 23, 2022Apr, 2022
7th International Conference on Pharmaceutical & Medical Device Sector
Apr 25 - Apr 27, 2022 Dr. Ambedkar International Centre, Janpath, New DelhiSep, 2021
Virtual Conclave on Integrating Methods of Pharmaco-economics to accelerate Healthcare Transformation 2.0 (IMPACT 2.0)
Sep 23, 2021 Virtual Platform, 9:30am - 12:25pmFeb, 2021
Jan, 2021
COVID Vaccine Rollout - Key Learning’s and preparedness for Phase 2
Jan 22, 2021 Virtual PlatformDec, 2020
Central and West conclave of the Spotlight on Visually Impaired in the wake of COVID-19
Dec 22, 2020 Virtual PlatformNov, 2020
Jun, 2020
National Sickle Cell Conclave: World Sickle Cell Day 2020
Jun 19, 2020 Virtual Platform, 11:00 AM - 01:00 PMMar, 2020
Dec, 2019
Nov, 2019
Sep, 2019
INDIA PAVILION AT PHARMATECH EXPO 2019
Sep 17 - Sep 19, 2019 ACCO International Exhibition Centre, Kiev, UkraineNov, 2018
Feb, 2018
India Pharma 2018: International Exhibition & Conference on Pharmaceutical Industry
Feb 15 - Feb 17, 2018 Bengaluru, KarnatakaMar, 2017
Feb, 2017
2nd International Exhibition & Conference on Pharmaceutical Industry
Feb 11 - Feb 13, 2017 BengaluruJun, 2015
FICCI Life Sciences Conference 2015 'Pharma Vision 2030: Building India's Global Relevance'
Jun 05, 2015 New DelhiApr, 2015
Regional GMP Strengthening Workshop for Indian Pharmaceutical Manufacturers and State Regulators” Focused on GMP in production of Active Pharmaceutical Ingredients and Oral Solid Dosage Forms
Apr 22 - Apr 24, 2015 Ahmedabad, Bangalore and GoaMar, 2015
Feb, 2015
GMP Strengthening for Indian Pharmaceutical Manufacturers focused on GMP in production of Active Pharmaceutical Ingredients and Oral Solid Dosage Forms
Feb 19, 2015 ChennaiMar, 2014
Jan, 2014
Regional workshops on GMP Strengthening for Indian Pharmaceutical Manufacturers focused on GMP in production of Active Pharmaceutical Ingredients and Oral Solid Dosage Forms
Jan 29 - Feb 06, 2014 Hyderabad , Ahmedabad, ChandigarhSep, 2013
Roundtable Discussion with Indian Pharmaceuticals & Diagnostics Industry Leaders & UNITAID Executive Director
Sep 02, 2013 FICCI, New DelhiDec, 2012
Nov, 2011
Nov, 2010
Nov, 2009
Competition Law and Pharmaceutical Industry - Opportunities and Challenges
Nov 25, 2009 New DelhiChair
Arjun Juneja
Chief Operating Officer Mankind Pharmaceuticals Ltd.Co-Chair
Ms Swati Dalal
Managing Director Abbott Primary Care, IndiaCo-Chair
Mr Siddharth Mittal
Managing Director & CEO Biocon LtdCo-Chair
Mr Amitabh Dube
Country President Novartis IndiaCo-Chair
Mr Sanjiv Navangul
CEO & Managing Director Bharat Serum & Vaccines LtdMentor
Mr Pankaj R. Patel
Chairman Zydus LifesciencesUniform Code of Pharmaceuticals Marketing Practices (UCPMP)
Download PDFDrug Discovery and Development - Business Opportunities in India
Download PDFSwachhata Hi Sewa - Plastic Waste Management and Banning of Single Use Plastics (SUPs): Action Plan of Department of Pharmaceuticals
Download PDFMandaviya inaugurates 40 new facilities to manufacture bulk drugs, medical devices
India set to become global hub of medical technology, says Union Minister
India set to emerge global production hub for medical devices: Mansukh Mandaviya
'Import of medicine raw materials down by 25%’: Union Minister Mansukh Mandaviya
Govt mulling policy to boost manufacturing of patented drugs: Mansukh Mandaviya
Bucking the pandemic: India's on its way to become the world's pharmaceutical hub
Indian pharma market expected to hit $130 billion by 2030: D V Sadananda Gowda
6th Edition of 'India Pharma & India Medical Device 2021' on 25-26 Feb & 1-2 March 2021
Healthcare continues to be an integral part of the Government’s priorities
Healthcare needs a unified regulator for drugs and devices, advise experts
Pharma & Medical devices industry should gearup for 'Ayushman Bharat' : Anant Kumar
"Decoding Homeopathy" - A One day National Homeopathy Conference held in Chennai
Govt working on a scheme to strengthen Indian Medical Device sector: Secretary, Department of Pharmaceuticals, GoI
Detail PageDr Mansukh Mandaviya inaugurates 51 greenfield projects under PLI scheme for Bulk Drugs and Medical Devices
Detail PageBhagwanth Khuba, Union Minister of State for Chemicals & Fertilizers, GoI addresses valedictory session of ‘India MedTech Expo 2023’, Gandhinagar,Gujarat
Detail PageGovernment has formulated a scheme namely ‘Promotion of Research and Innovation in Pharma MedTech Sector’
Detail PageWorld eager to invest in India’s MedTech sector: Dr Mansukh Mandaviya
Detail PageGovt adopting holistic approach to make India a global hub of Medical Devices, set to become $50 billion industry soon: Dr Mansukh Mandaviya
Detail PageCholesterol check must become part of diabetes and BP screening to improve India's Heart Health: Experts
Detail PagePharmacoeconomics can aid policy makers and healthcare providers in evaluating affordability and access to reasonable drug use: Dr Sangita Reddy, Immediate Past President, FICCI
Detail PageIndian Pharma market is expected to grow to US$ 130 billion by 2030: DV Sadananda Gowda
Detail PageState governments geared up to tackle vision care during pandemic: Experts
Detail PageNeed to create more awareness across the country on vision care: Industry Experts
Detail PageGovt to soon formulate comprehensive eye care package for visually impaired: Economic Advisor, MoH&FW
Detail Pagee-Pharmacies can collaborate with CSCs to improve healthcare access in rural areas: MoS Health & Family Welfare
Detail PageFICCI Statement on Bulk Drug Park and Production Linked Incentive (PLI) Scheme
Detail PageGovt to come up with regulatory guidelines for OTC drugs - Dy Drug Controller, MoH&FW
Detail PageFICCI applauds ICMR strategy for calibrated ramping up of the covid-19 testing
Detail PageQuality, trust, transparency critical for the healthcare industry: Joint Secretary, Department of Commerce
Detail PageNeed for effective public health approach on the ground to control COVID-19: Dr V K Paul, Member, NITI Aayog
Detail PageIndustry should come forward to develop Pharma and Medical Devices parks - Mansukh Mandaviya
Detail PageNeed to create more awareness in rural, tribal areas on Sickle Cell disease and its management - Arjun Munda
Detail PageFICCI launches first international 'Virtual Healthcare and Hygiene Expo 2020'
Detail PageFICCI welcomes Cabinet decision on Bulk Drug Parks
Detail PageIndia Pharma 2020 and India Medical Device 2020 focuses on clarity on changing regulatory scenarios
Detail PageAccess to affordable medical care and National Health Protection Scheme, priority of Government: D V Sadananda Gowda
Detail PageIndia Pharma 2019 & India Medical Device 2019 on 18-19 Feb. in Bengaluru
Detail PageFICCI launches Self-regulation Code of Conduct for the e-pharmacy sector
Download PDFFICCI welcomes Department of Pharmaceutical's move towards broadbased stakeholder consultations
Download PDFIndian Pharma sector poised to become future world hub
Download PDFLeading journos recommend women to organize as pressure groups to increase their participation and numbers in politics
Download PDFProlonged crisis in Ukraine could affect Indian pharma companies
Download PDFJoint China-India Tendering for Global Pharma Export Orders Possible Given China's Strengths in API Production, India's Capability in Formulations & Ability to Prepare Bid Documents: China Chamber
Download PDFGlobal Pharma Companies Looking to India Advantage for Clinical Research Services: FICCI - E&Y Paper
Download PDF